Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Redhill Biopharma Ltd (NASDAQ:RDHL)

14.10
Delayed Data
As of 3:59pm ET
 -0.64 / -4.34%
Today’s Change
8.10
Today|||52-Week Range
16.54
+9.47%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Redhill Biopharma Ltd have a median target of 29.50, with a high estimate of 36.00 and a low estimate of 25.00. The median estimate represents a +109.22% increase from the last price of 14.10.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Redhill Biopharma Ltd. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.54
Sales
$1,000.0K
Reporting Date
Nov 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -7.43%
 
 
 
 
 
 
Growthannually -6.61%
 
 
 
 
 
 

Sales

Growthquarterly 99,900.00%
 
 
 
 
 
 
Growthannually 29,916.67%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.